HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors.

AbstractRATIONALE:
We evaluated the effects of haloperidol and its metabolites on capsaicin-induced mechanical hypersensitivity (allodynia) and on nociceptive pain induced by punctate mechanical stimuli in mice.
RESULTS:
Subcutaneous administration of haloperidol or its metabolites I or II (reduced haloperidol) dose-dependently reversed capsaicin-induced (1 microg, intraplantar) mechanical hypersensitivity of the hind paw (stimulated with a nonpainful, 0.5-g force, punctate stimulus). The order of potency of these drugs to induce antiallodynic effects was the order of their affinity for brain sigma-1 (sigma(1)) receptor ([(3)H](+)-pentazocine-labeled). Antiallodynic activity of haloperidol and its metabolites was dose-dependently prevented by the selective sigma(1) receptor agonist PRE-084, but not by naloxone. These results suggest the involvement of sigma(1) receptors, but discard any role of the endogenous opioid system, on the antiallodynic effects. Dopamine receptor antagonism also appears unlikely to be involved in these effects, since the D(2)/D(3) receptor antagonist (-)-sulpiride, which had no affinity for sigma(1) receptors, showed no antiallodynic effect. None of these drugs modified hind-paw withdrawal after a painful (4 g force) punctate mechanical stimulus in noncapsaicin-sensitized animals. As expected, the control drug gabapentin showed antiallodynic but not antinociceptive activity, whereas clonidine exhibited both activities and rofecoxib, used as negative control, showed neither.
CONCLUSION:
These results show that haloperidol and its metabolites I and II produce antiallodynic but not antinociceptive effects against punctate mechanical stimuli and suggest that their antiallodynic effect may be due to blockade of sigma(1) receptors but not to dopamine receptor antagonism.
AuthorsJosé M Entrena, Enrique J Cobos, Francisco R Nieto, Cruz M Cendán, José M Baeyens, Esperanza Del Pozo
JournalPsychopharmacology (Psychopharmacology (Berl)) Vol. 205 Issue 1 Pg. 21-33 (Jul 2009) ISSN: 1432-2072 [Electronic] Germany
PMID19326101 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dopamine Antagonists
  • Morpholines
  • Narcotic Antagonists
  • Receptors, sigma
  • sigma-1 receptor
  • Tritium
  • 2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate
  • 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol
  • Naloxone
  • Haloperidol
  • Pentazocine
  • Capsaicin
Topics
  • Analysis of Variance
  • Animals
  • Brain (cytology, drug effects, metabolism)
  • Capsaicin (pharmacology)
  • Disease Models, Animal
  • Dopamine Antagonists (pharmacology, therapeutic use)
  • Dose-Response Relationship, Drug
  • Female
  • Haloperidol (analogs & derivatives, metabolism, pharmacology, therapeutic use)
  • Hyperalgesia (chemically induced, metabolism, pathology)
  • Mice
  • Morpholines (pharmacology)
  • Motor Activity (drug effects)
  • Naloxone (pharmacology)
  • Narcotic Antagonists (pharmacology)
  • Pain (drug therapy, etiology)
  • Pain Measurement
  • Pain Threshold (drug effects)
  • Pentazocine (metabolism)
  • Physical Stimulation (adverse effects)
  • Protein Binding (drug effects)
  • Radioligand Assay (methods)
  • Reaction Time (drug effects)
  • Receptors, sigma (agonists, antagonists & inhibitors, metabolism)
  • Rotarod Performance Test
  • Tritium (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: